Golden Finance News | Tigermed (03347) started well, as of the time of publication, rose by 12.47%, at 45.1 Hong Kong dollars, with a turnover of 21.39 million Hong Kong dollars. It should be noted that the stock has risen by 68% in the past 6 trading days.
On the news front, the company recently announced plans to acquire a total of 40.5650% equity of BioGerm Pharma held by dian diagnostics group and Suzhou Yingkai through cash payment, with a total purchase price of 0.14 billion yuan. After the completion of this transaction, the company and its wholly-owned subsidiary Jiaxing Xinge will directly and indirectly hold a total of 72.8169% equity of BioGerm Pharma, which will be consolidated into the company's financial statements. This transaction constitutes a related party transaction.
